$7.40
-0.1-1.33%
Pre-Market: 5:36 PM EDT
15 minutes delayed
Adverum Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adverum Biotechnologies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.89 | $-1.45 | 38.6 % |
Mar 2024 | 2024-05-09 | $-1.50 | $-1.41 | -6.38 % |
Dec 2023 | 2024-03-18 | $-2.30 | $-3.40 | 32.4 % |
Sep 2023 | 2023-11-09 | $-3.30 | $-3.20 | -3.12 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $0 | $110.00K | -100.0 % |
Jun 2021 | 2021-08-05 | $0 | $60.00K | -100.0 % |
Mar 2021 | 2021-05-06 | $7.50M | $60.00K | 12400.0 % |
Dec 2020 | 2021-03-01 | $0 | $80.00K | -100.0 % |
Adverum Biotechnologies (ADVM) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.89, which beat the estimate of $-1.45.
The Actual Revenue was $0K, which missed the estimate of $110K.
Browse earnings estimates, EPS, and revenue on all stocks.